<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36322143</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>06</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Reversing lysosome-ribosome circuit dysregulation mitigates C9FTD/ALS neurodegeneration and behaviors.</ArticleTitle><Pagination><StartPage>1252</StartPage><EndPage>1265</EndPage><MedlinePgn>1252-1265</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/ddac271</ELocationID><Abstract><AbstractText>G4C2 repeat expansion in C9orf72 causes the most common familial frontotemporal dementia and amyotrophic lateral sclerosis (C9FTD/ALS). The pathogenesis includes haploinsufficiency of C9orf72, which forms a protein complex with Smcr8, as well as G4C2 repeat-induced gain of function including toxic dipeptide repeats (DPRs). The key in vivo disease-driving mechanisms and how loss- and gain-of-function interplay remain poorly understood. Here, we identified dysregulation of a lysosome-ribosome biogenesis circuit as an early and key disease mechanism using a physiologically relevant mouse model with combined loss- and gain-of-function across the aging process. C9orf72 deficiency exacerbates FTD/ALS-like pathologies and behaviors in C9ORF72 bacterial artificial chromosome (C9-BAC) mice with G4C2 repeats under endogenous regulatory elements from patients. Single nucleus RNA sequencing (snRNA-seq) and bulk RNA-seq revealed that C9orf72 depletion disrupts lysosomes in neurons and leads to transcriptional dysregulation of ribosomal protein genes, which are likely due to the proteotoxic stress response and resemble ribosomopathy defects. Importantly, ectopic expression of C9orf72 or its partner Smcr8 in C9FTD/ALS mutant mice promotes lysosomal functions and restores ribosome biogenesis gene transcription, resulting in the mitigation of DPR accumulation, neurodegeneration as well as FTD/ALS-like motor and cognitive behaviors. Therefore, we conclude that loss- and gain-of-function crosstalk in C9FTD/ALS converges on neuronal dysregulation of a lysosome-ribosome biogenesis circuit leading to proteotoxicity, neurodegeneration and behavioral defects.</AbstractText><CopyrightInformation>Published by Oxford University Press 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Craniofacial Molecular Biology, University of Southern California (USC), Los Angeles, CA 90033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Craniofacial Molecular Biology, University of Southern California (USC), Los Angeles, CA 90033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Center for Craniofacial Molecular Biology, University of Southern California (USC), Los Angeles, CA 90033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Craniofacial Molecular Biology, University of Southern California (USC), Los Angeles, CA 90033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Craniofacial Molecular Biology, University of Southern California (USC), Los Angeles, CA 90033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Yuanning</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Craniofacial Molecular Biology, University of Southern California (USC), Los Angeles, CA 90033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadan</LastName><ForeName>Jotham</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Craniofacial Molecular Biology, University of Southern California (USC), Los Angeles, CA 90033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jian-Fu</ForeName><Initials>JF</Initials><Identifier Source="ORCID">0000-0002-9474-5673</Identifier><AffiliationInfo><Affiliation>Center for Craniofacial Molecular Biology, University of Southern California (USC), Los Angeles, CA 90033, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21AG070681</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DE030901</GrantID><Acronym>DE</Acronym><Agency>NIDCR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG075665</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000618232">SMCR8 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012270" MajorTopicYN="N">Ribosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>7</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>12</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36322143</ArticleId><ArticleId IdType="pmc">PMC10077508</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddac271</ArticleId><ArticleId IdType="pii">6794014</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Renton, A.E., Majounie, E., Waite, A., Sim&#xf3;n-S&#xe1;nchez, J., Rollinson, S., Gibbs, J.R., Schymick, J.C., Laaksovirta, H., van &#xa0;Swieten, J.C., Myllykangas, L. &#xa0;et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron, 72, 257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez, M., Mackenzie, I.R., Boeve, B.F., Boxer, A.L., Baker, M., Rutherford, N.J., Nicholson, A.M., Finch, N.A., Flynn, H., Adamson, J. &#xa0;et al. (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, 72, 245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari, R., Kapogiannis, D., Huey, E.D. and Momeni, P. (2011) FTD and ALS: a tale of two diseases. Curr. Alzheimer Res., 8, 273&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3801195</ArticleId><ArticleId IdType="pubmed">21222600</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong, M.J. (2008) The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler., 9, 323&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">18752088</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M. &#xa0;et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y. and Oda, T. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun., 351, 602&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, F.-B., Almeida, S. and Lopez-Gonzalez, R. (2017) Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder. EMBO J., 36, 2931&#x2013;2950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641681</ArticleId><ArticleId IdType="pubmed">28916614</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling, S.-C., Polymenidou, M. and Cleveland, D.W. (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron, 79, 416&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, J.P., Brown, R.H. and Cleveland, D.W. (2016) Decoding ALS: from genes to mechanism. Nature, 539, 197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron, T.F. and Petrucelli, L. (2018) Disease mechanisms of C9ORF72 repeat expansions. Cold Spring Harb Perspect Med, 8, a024224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5880161</ArticleId><ArticleId IdType="pubmed">28130314</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon, E.G., Lu, L., Sharma, A., Yamazaki, T., Tang, T., Shneider, N.A. and Manley, J.L. (2016) The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. elife, 5, 345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5050020</ArticleId><ArticleId IdType="pubmed">27623008</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron, T.F., Bieniek, K.F., Zhang, Y.-J., Jansen-West, K., Ash, P.E.A., Caulfield, T., Daughrity, L., Dunmore, J.H., Castanedes-Casey, M., Chew, J. &#xa0;et al. (2013) Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol., 126, 829&#x2013;844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler, A.R., Donnelly, C.J., Periz, G., Simko, E.A.J., Shaw, P.G., Kim, M.-S., Maragakis, N.J., Troncoso, J.C., Pandey, A., Sattler, R., Rothstein, J.D. and Wang, J. (2014) C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature, 507, 195&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez, R., Lu, Y., Gendron, T.F., Karydas, A., Tran, H., Yang, D., Petrucelli, L., Miller, B.L., Almeida, S. and Gao, F.-B. (2016) Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron, 92, 383&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y.-J., Gendron, T.F., Ebbert, M.T.W., O'Raw, A.D., Yue, M., Jansen-West, K., Zhang, X., Prudencio, M., Chew, J., Cook, C.N. &#xa0;et al. (2018) Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Nat. Med., 24, 1136&#x2013;1142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6520050</ArticleId><ArticleId IdType="pubmed">29942091</ArticleId></ArticleIdList></Reference><Reference><Citation>Loveland, A.B., Svidritskiy, E., Susorov, D., Lee, S., Park, A., Zvornicanin, S., Demo, G., Gao, F.-B. and Korostelev, A.A. (2022) Ribosome inhibition by C9ORF72-ALS/FTD-associated poly-PR and poly-GR proteins revealed by cryo-EM. Nat. Commun., 13, 2776&#x2013;2713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9120013</ArticleId><ArticleId IdType="pubmed">35589706</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin, M., Pfister, V., Gaucherot, A., Ruffenach, F., Negroni, L., Sellier, C. and Charlet-Berguerand, N. (2020) Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. EMBO J., 39, e100574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7024836</ArticleId><ArticleId IdType="pubmed">31930538</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu, Q., Jiang, J., Gendron, T.F., McAlonis-Downes, M., Jiang, L., Taylor, A., Diaz Garcia, S., Ghosh Dastidar, S., Rodriguez, M.J., King, P. &#xa0;et al. (2020) Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat. Neurosci., 23, 615&#x2013;624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang, C., Shao, Q., Zhang, W., Yang, M., Chang, Q., Chen, R. and Chen, J.-F. (2019) Smcr8 deficiency disrupts axonal transport-dependent lysosomal function and promotes axonal swellings and gain of toxicity in C9ALS/FTD mouse models. Hum. Mol. Genet., 28, 3940&#x2013;3953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7282195</ArticleId><ArticleId IdType="pubmed">31625563</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao, Q., Liang, C., Chang, Q., Zhang, W., Yang, M. and Chen, J.-F. (2019) C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent manner. Acta Neuropathol Commun, 7, 32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6398253</ArticleId><ArticleId IdType="pubmed">30832726</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao, Q., Yang, M., Liang, C., Ma, L., Zhang, W., Jiang, Z., Luo, J., Lee, J.-K., Liang, C. and Chen, J.-F. (2019) C9orf72 and smcr8 mutant mice reveal MTORC1 activation due to impaired lysosomal degradation and exocytosis. Autophagy, 72, 1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8386604</ArticleId><ArticleId IdType="pubmed">31847700</ArticleId></ArticleIdList></Reference><Reference><Citation>Laplante, M. and Sabatini, D.M. (2012) mTOR signaling in growth control and disease. Cell, 149, 274&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3331679</ArticleId><ArticleId IdType="pubmed">22500797</ArticleId></ArticleIdList></Reference><Reference><Citation>Recasens-Alvarez, C., Alexandre, C., Kirkpatrick, J., Nojima, H., Huels, D.J., Snijders, A.P. and Vincent, J.-P. (2021) Ribosomopathy-associated mutations cause proteotoxic stress that is alleviated by TOR inhibition. Nat. Cell Biol., 23, 127&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116740</ArticleId><ArticleId IdType="pubmed">33495632</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumgartner, M.E., Dinan, M.P., Langton, P.F., Kucinski, I. and Piddini, E. (2021) Proteotoxic stress is a driver of the loser status and cell competition. Nat. Cell Biol., 23, 136&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116823</ArticleId><ArticleId IdType="pubmed">33495633</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, M., Liang, C., Swaminathan, K., Herrlinger, S., Lai, F., Shiekhattar, R. and Chen, J.-F. (2016) A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci. Adv., 2, e1601167&#x2013;e1601167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5010369</ArticleId><ArticleId IdType="pubmed">27617292</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y., Pattamatta, A., Zu, T., Reid, T., Bardhi, O., Borchelt, D.R., Yachnis, A.T. and Ranum, L.P.W. (2016) C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron, 90, 521&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers, M., Blokhuis, A.M., Westeneng, H.-J., Terpstra, M.L., Zundel, C.A.C., Vieira de S&#xe1;, R., Schellevis, R.D., Waite, A.J., Blake, D.J., Veldink, J.H., van den Berg, L.H. and Pasterkamp, R.J. (2015) C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann. Neurol., 78, 426&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4744979</ArticleId><ArticleId IdType="pubmed">26044557</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Rourke, J.G., Bogdanik, L., Y&#xe1;&#xf1;ez, A., Lall, D., Wolf, A.J., Muhammad, A.K.M.G., Ho, R., Carmona, S., Vit, J.P., Zarrow, J. &#xa0;et al. (2016) C9orf72 is required for proper macrophage and microglial function in mice. Science, 351, 1324&#x2013;1329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry, A., Suzuki, N., Wang, J.-Y., Moccia, R., Mordes, D.A., Stewart, M.H., Suzuki-Uematsu, S., Ghosh, S., Singh, A., Merkle, F.T. &#xa0;et al. (2016) Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci. Transl. Med., 8, 347ra93&#x2013;347ra93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi, Y., Lin, S., Staats, K.A., Li, Y., Chang, W.-H., Hung, S.-T., Hendricks, E., Linares, G.R., Wang, Y., Son, E.Y. &#xa0;et al. (2018) Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med., 24, 313&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie, I.R.A., Frick, P., Gr&#xe4;sser, F.A., Gendron, T.F., Petrucelli, L., Cashman, N.R., Edbauer, D., Kremmer, E., Prudlo, J., Troost, D. and Neumann, M. (2015) Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol., 130, 845&#x2013;861.</Citation><ArticleIdList><ArticleId IdType="pubmed">26374446</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie, I.R.A., Frick, P. and Neumann, M. (2014) The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol., 127, 347&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">24356984</ArticleId></ArticleIdList></Reference><Reference><Citation>May, S., Hornburg, D., Schludi, M.H., Arzberger, T., Rentzsch, K., Schwenk, B.M., Gr&#xe4;sser, F.A., Mori, K., Kremmer, E., Banzhaf-Strathmann, J. &#xa0;et al. (2014) C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathol., 128, 485&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159571</ArticleId><ArticleId IdType="pubmed">25120191</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y.-J., Gendron, T.F., Grima, J.C., Sasaguri, H., Jansen-West, K., Xu, Y.-F., Katzman, R.B., Gass, J., Murray, M.E., Shinohara, M. &#xa0;et al. (2016) C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat. Neurosci., 19, 668&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5138863</ArticleId><ArticleId IdType="pubmed">26998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska, S., Gr&#xf6;nke, S., Niccoli, T., Ridler, C.E., Clayton, E.L., Devoy, A., Moens, T., Norona, F.E., Woollacott, I.O.C., Pietrzyk, J. &#xa0;et al. (2014) C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science, 345, 1192&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi, M.H., Becker, L., Garrett, L., Gendron, T.F., Zhou, Q., Schreiber, F., Popper, B., Dimou, L., Strom, T.M., Winkelmann, J. &#xa0;et al. (2017) Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss. Acta Neuropathol., 134, 241&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5508040</ArticleId><ArticleId IdType="pubmed">28409281</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan, K.Y., Jang, M.J., Yoo, B.B., Greenbaum, A., Ravi, N., Wu, W.-L., S&#xe1;nchez-Guardado, L., Lois, C., Mazmanian, S.K., Deverman, B.E. and Gradinaru, V. (2017) Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat. Neurosci., 20, 1172&#x2013;1179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5529245</ArticleId><ArticleId IdType="pubmed">28671695</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed, Z., Sheng, H., Xu, Y.-F., Lin, W.-L., Innes, A.E., Gass, J., Yu, X., Wuertzer, C.A., Hou, H., Chiba, S. &#xa0;et al. (2010) Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging. Am. J. Pathol., 177, 311&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2893674</ArticleId><ArticleId IdType="pubmed">20522652</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Garc&#xed;a, A., Kun, A., Calero, O., Medina, M. and Calero, M. (2018) An Overview of the Role of Lipofuscin in Age-Related Neurodegeneration. Front. Neurosci., 12, 464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6041410</ArticleId><ArticleId IdType="pubmed">30026686</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert, B., Kos-Braun, I.C., Henras, A.K., Dez, C., Rueda, M.P., Zhang, X., Gadal, O., Kos, M. and Shore, D. (2019) A ribosome assembly stress response regulates transcription to maintain proteome homeostasis. elife, 8, e45002, 1&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6579557</ArticleId><ArticleId IdType="pubmed">31124783</ArticleId></ArticleIdList></Reference><Reference><Citation>Tye, B.W., Commins, N., Ryazanova, L.V., W&#xfc;hr, M., Springer, M., Pincus, D. and Churchman, L.S. (2019) Proteotoxicity from aberrant ribosome biogenesis compromises cell fitness. elife, 8, e43002, 1&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6453566</ArticleId><ArticleId IdType="pubmed">30843788</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills, E.W. and Green, R. (2017) Ribosomopathies: there's strength in numbers. Science, 358, eaan2755.</Citation><ArticleIdList><ArticleId IdType="pubmed">29097519</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelick, P.C. and Trainor, P.A. (2015) Ribosomopathies: global process, tissue specific defects. Rare Dis, 3, e1025185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4590025</ArticleId><ArticleId IdType="pubmed">26442198</ArticleId></ArticleIdList></Reference><Reference><Citation>Khajuria, R.K., Munschauer, M., Ulirsch, J.C., Fiorini, C., Ludwig, L.S., McFarland, S.K., Abdulhay, N.J., Specht, H., Keshishian, H., Mani, D.R. &#xa0;et al. (2018) Ribosome levels selectively regulate translation and lineage commitment in human hematopoiesis. Cell, 173, 90&#x2013;103.e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5866246</ArticleId><ArticleId IdType="pubmed">29551269</ArticleId></ArticleIdList></Reference><Reference><Citation>Farley-Barnes, K.I., Ogawa, L.M. and Baserga, S.J. (2019) Ribosomopathies: old concepts. New Controversies. Trends Genet., 35, 754&#x2013;767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6852887</ArticleId><ArticleId IdType="pubmed">31376929</ArticleId></ArticleIdList></Reference><Reference><Citation>Aladesuyi Arogundade, O., Nguyen, S., Leung, R., Wainio, D., Rodriguez, M. and Ravits, J. (2021) Nucleolar stress in C9orf72 and sporadic ALS spinal motor neurons precedes TDP-43 mislocalization. Acta Neuropathol Commun, 9, 26&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7885352</ArticleId><ArticleId IdType="pubmed">33588953</ArticleId></ArticleIdList></Reference><Reference><Citation>Mordes, D.A., Morrison, B.M., Ament, X.H., Cantrell, C., Mok, J., Eggan, P., Xue, C., Wang, J.-Y., Eggan, K. and Rothstein, J.D. (2020) Absence of survival and motor deficits in 500 repeat C9ORF72 BAC mice. Neuron, 108, 775&#x2013;783.e4.</Citation><ArticleIdList><ArticleId IdType="pubmed">33022228</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen, L., Laboissonniere, L.A., Guo, S., Pilotto, F., Scheidegger, O., Oestmann, A., Hammond, J.W., Li, H., Hyysalo, A., Peltola, R. &#xa0;et al. (2020) Survival and motor phenotypes in FVB C9-500 ALS/FTD BAC transgenic mice reproduced by multiple labs. Neuron, 108, 784&#x2013;796.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8281452</ArticleId><ArticleId IdType="pubmed">33022226</ArticleId></ArticleIdList></Reference><Reference><Citation>Schauwecker, P.E. (2003) Genetic basis of kainate-induced excitotoxicity in mice: phenotypic modulation of seizure-induced cell death. Epilepsy Res., 55, 201&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">12972174</ArticleId></ArticleIdList></Reference><Reference><Citation>Schauwecker, P.E. (2002) Modulation of cell death by mouse genotype: differential vulnerability to excitatory amino acid-induced lesions. Exp. Neurol., 178, 219&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">12504881</ArticleId></ArticleIdList></Reference><Reference><Citation>Yardeni, T., Eckhaus, M., Morris, H.D., Huizing, M. and Hoogstraten-Miller, S. (2011) Retro-orbital injections in mice. Lab Anim (NY), 40, 155&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3158461</ArticleId><ArticleId IdType="pubmed">21508954</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>